Log in

NASDAQ:IRMD - Iradimed Stock Price, Forecast & News

$25.67
-0.09 (-0.35 %)
(As of 12/16/2019 03:17 AM ET)
Today's Range
$24.64
Now: $25.67
$25.92
50-Day Range
$21.72
MA: $23.29
$25.69
52-Week Range
$16.68
Now: $25.67
$29.80
Volume48,202 shs
Average Volume64,804 shs
Market Capitalization$294.69 million
P/E Ratio59.70
Dividend YieldN/A
Beta1.48
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:IRMD
CUSIPN/A
Phone407-677-8022

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$30.44 million
Cash Flow$0.58 per share
Book Value$3.84 per share

Profitability

Net Income$6.30 million

Miscellaneous

Employees95
Market Cap$294.69 million
Next Earnings Date2/5/2020 (Estimated)
OptionableNot Optionable

Receive IRMD News and Ratings via Email

Sign-up to receive the latest news and ratings for IRMD and its competitors with MarketBeat's FREE daily newsletter.


Iradimed (NASDAQ:IRMD) Frequently Asked Questions

What is Iradimed's stock symbol?

Iradimed trades on the NASDAQ under the ticker symbol "IRMD."

How were Iradimed's earnings last quarter?

Iradimed Corp (NASDAQ:IRMD) released its quarterly earnings data on Wednesday, October, 30th. The medical equipment provider reported $0.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.13 by $0.07. The medical equipment provider earned $9.96 million during the quarter, compared to the consensus estimate of $9.85 million. Iradimed had a net margin of 22.51% and a return on equity of 16.24%. View Iradimed's Earnings History.

When is Iradimed's next earnings date?

Iradimed is scheduled to release their next quarterly earnings announcement on Wednesday, February 5th 2020. View Earnings Estimates for Iradimed.

Has Iradimed been receiving favorable news coverage?

News headlines about IRMD stock have trended somewhat negative on Monday, InfoTrie Sentiment reports. The research firm identifies positive and negative media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Iradimed earned a coverage optimism score of -1.6 on InfoTrie's scale. They also assigned news headlines about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Iradimed.

Are investors shorting Iradimed?

Iradimed saw a decrease in short interest in November. As of November 29th, there was short interest totalling 408,800 shares, a decrease of 8.5% from the November 14th total of 447,000 shares. Based on an average daily trading volume, of 67,600 shares, the days-to-cover ratio is presently 6.0 days. Approximately 7.5% of the company's shares are sold short. View Iradimed's Current Options Chain.

Who are some of Iradimed's key competitors?

What other stocks do shareholders of Iradimed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Iradimed investors own include NVIDIA (NVDA), Intuitive Surgical (ISRG), Micron Technology (MU), Palo Alto Networks (PANW), BioTelemetry (BEAT), Alphabet (GOOG), IntriCon (IIN), Paypal (PYPL), GrubHub (GRUB) and Mastercard (MA).

Who are Iradimed's key executives?

Iradimed's management team includes the folowing people:
  • Mr. Roger E. Susi, Founder, Chairman, CEO & Pres (Age 66)
  • Mr. Christopher K. Scott, CFO & Sec. (Age 49)
  • Mr. John McCreery, Chief Operating Officer (Age 64)
  • Mr. Brent Johnson, Exec. VP of Worldwide Sales & Marketing (Age 60)
  • Mr. Louis Waldman, Controller (Age 64)

Who are Iradimed's major shareholders?

Iradimed's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Cadence Capital Management LLC (1.04%), Russell Investments Group Ltd. (0.63%), Roubaix Capital LLC (0.58%), State Street Corp (0.50%), Navellier & Associates Inc (0.25%) and Millennium Management LLC (0.19%). Company insiders that own Iradimed stock include Anthony Vuoto, Brent Johnson, Christopher K Scott, Francis X Casey, John K Mccreery, Louis S Waldman, Monty K Allen, Roger E Susi and Steven M Nardi. View Institutional Ownership Trends for Iradimed.

Which major investors are selling Iradimed stock?

IRMD stock was sold by a variety of institutional investors in the last quarter, including Navellier & Associates Inc and Cadence Capital Management LLC. Company insiders that have sold Iradimed company stock in the last year include Anthony Vuoto, Brent Johnson, Louis S Waldman, Monty K Allen and Steven M Nardi. View Insider Buying and Selling for Iradimed.

Which major investors are buying Iradimed stock?

IRMD stock was bought by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Roubaix Capital LLC, Millennium Management LLC, Squarepoint Ops LLC, Barclays PLC, State Street Corp and Tower Research Capital LLC TRC. View Insider Buying and Selling for Iradimed.

How do I buy shares of Iradimed?

Shares of IRMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Iradimed's stock price today?

One share of IRMD stock can currently be purchased for approximately $25.67.

How big of a company is Iradimed?

Iradimed has a market capitalization of $294.69 million and generates $30.44 million in revenue each year. The medical equipment provider earns $6.30 million in net income (profit) each year or $0.43 on an earnings per share basis. Iradimed employs 95 workers across the globe.View Additional Information About Iradimed.

What is Iradimed's official website?

The official website for Iradimed is http://www.iradimed.com/.

How can I contact Iradimed?

Iradimed's mailing address is 1025 Willa Springs Dr., Winter Springs FL, 32708. The medical equipment provider can be reached via phone at 407-677-8022 or via email at [email protected]


MarketBeat Community Rating for Iradimed (NASDAQ IRMD)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  216 (Vote Outperform)
Underperform Votes:  223 (Vote Underperform)
Total Votes:  439
MarketBeat's community ratings are surveys of what our community members think about Iradimed and other stocks. Vote "Outperform" if you believe IRMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IRMD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel